Showing results (81-90 of 147) with videos related to
Sort By:
Pageof 15
Lipids|July 27, 1999
The inhibition of endothelial activation by unsaturated fatty acidsR De Caterina, M Spiecker, G Solaini, et al.Pharmacological Research|October 1, 1993
Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in manD Giannessi, G Lazzerini, P Filipponi, et al.Vascular Pharmacology|December 3, 2014
Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemiaV B Nooney, N L Hurst, Y Y Chirkov, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 11, 1998
Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspectsA Sagripanti, A Ferretti, D Giannessi, et al.The American Journal of Cardiology|June 1, 1984
Inhibition of platelet function by injectable isosorbide dinitrateR De Caterina, D Giannessi, F Crea, et al.Zeitschrift Fur Kardiologie|January 1, 1983
Antiplatelet effects of isosorbide dinitrate in manR De Caterina, D Giannessi, F Crea, et al.La Clinica Terapeutica|January 1, 1993
[The use of picotamide in nephropathy with mesangial IgA deposits. The effect on thromboxane generation]A Sagripanti, A Cupisti, D Giannessi, et al.Clinical Science (London, England : 1979)|January 1, 1997
Urinary albumin excretion and atherosclerosis in essential hypertensionR Pedrinelli, K Lindpaintner, G Dell'Omo, et al.Surgery|September 1, 1985
Functional endothelial damage by high-potassium cardioplegic solutions to saphenous vein bypass graftsR De Caterina, B B Weksler, D R Alonso, et al.European Heart Journal|November 20, 1998
Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroupsR Lorenzoni, D Pagano, G Mazzotta, et al.Pageof 15